Drug intelligence / Profile preview

Ceftriaxone, Gentamicin, and Metronidazole Combination

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Oral
01

Overview

Based on the search results, I'll provide information about the combination of ceftriaxone, gentamicin, and metronidazole. The combination of ceftriaxone, gentamicin, and metronidazole is an antibiotic regimen used primarily for treating complicated intra-abdominal infections, perforated appendicitis, and pelvic inflammatory disease. This combination provides broad-spectrum coverage against various bacterial pathogens. ## Pharmacology and Mechanism of Action This triple antibiotic regimen combines three different antimicrobial agents with complementary mechanisms: - **Ceftriaxone**: A third-generation cephalosporin that works by inhibiting bacterial cell wall synthesis. It has excellent gram-negative coverage and a long half-life allowing for once-daily dosing[1][2]. - **Gentamicin**: An aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. It provides additional gram-negative coverage, particularly against Pseudomonas and other resistant organisms[1][5]. - **Metronidazole**: An antibiotic effective against anaerobic bacteria and certain parasites. It works by disrupting DNA synthesis in susceptible organisms[1][7]. ## Clinical Applications The combination is used in several clinical scenarios: 1. **Perforated Appendicitis**: Traditionally used as a standard triple antibiotic regimen for perforated appendicitis in children, though studies have shown that a simpler regimen of ceftriaxone and metronidazole alone may be equally effective[1]. 2. **Complicated Intra-abdominal Infections**: Used as a treatment option for complicated intra-abdominal infections, particularly in pediatric populations[5][6]. 3. **Pelvic Inflammatory Disease (PID)**: Used as part of parenteral treatment regimens for PID[7]. ## Dosing Considerations Typical dosing regimens include: - **Ceftriaxone**: 1-2 g IV every 24 hours[5][7] - **Gentamicin**: Loading dose IV or IM (2 mg/kg body weight), followed by maintenance dose (1.5 mg/kg) every 8 hours; alternatively, single daily dosing (3-5 mg/kg) can be used[7] - **Metronidazole**: 500 mg IV or orally every 8-12 hours[7] ## Efficacy and Limitations Research has shown that achieving therapeutic levels of gentamicin can be challenging. In one study, only one-third of patients maintained therapeutic gentamicin levels throughout their antibiotic course despite careful monitoring[1]. This finding suggests that gram-negative coverage might not be the critical component of this regimen, as infectious complications were not higher in patients with subtherapeutic gentamicin levels. ## Alternative Regimens Several studies have demonstrated that simpler regimens may be equally effective: 1. **Ceftriaxone + Metronidazole**: This two-drug combination has been shown to be as effective as the triple antibiotic regimen for infection control in perforated appendicitis, while being more cost-effective and easier to administer[1][3]. 2. **Cefoxitin alone**: Some studies suggest that cefoxitin monotherapy can be as effective as the combination of metronidazole and gentamicin for prophylaxis against postoperative septic complications in colorectal surgery[4]. 3. **Other Cephalosporins + Metronidazole**: Other third-generation cephalosporins (cefotaxime, ceftizoxime) combined with metronidazole are also recommended alternatives[5][6][7]. The choice between these regimens should be based on local antimicrobial resistance patterns, patient factors, and institutional guidelines.

Other names
triple antibiotic regimen
02

Targets

PBP (Penicillin-binding protein family)Bacterial Ribosome

Beyond the preview

Go deeper on Ceftriaxone, Gentamicin, and Metronidazole Combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceftriaxone, Gentamicin, and Metronidazole Combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call